A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)

BACKGROUND: We describe a randomized, non-blinded Phase II interventional study to assess the safety and efficacy of stereotactic ablative radiotherapy (SABR) for hormone-sensitive oligometastatic prostate adenocarcinoma, and to describe the biology of the oligometastatic state using immunologic, ce...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Radwan, Noura, Phillips, Ryan, Ross, Ashley, Rowe, Steven P., Gorin, Michael A., Antonarakis, Emmanuel S., Deville, Curtiland, Greco, Stephen, Denmeade, Samuel, Paller, Channing, Song, Daniel Y., Diehn, Maximilian, Wang, Hao, Carducci, Michael, Pienta, Kenneth J., Pomper, Martin G., DeWeese, Theodore L., Dicker, Adam, Eisenberger, Mario, Tran, Phuoc T.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5492934/
https://ncbi.nlm.nih.gov/pubmed/28662647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3455-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados